Virtus Health PEG
Delisted
The PEG Ratio (Price/Earnings-to-Growth) of Virtus Health (VRT.AX) as of Jul 25, 2026 is 1.37. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 126.02 — a change of -98.91% (lower).
Get this data via API
Financial Data API
PEG
1.37
YoY
-98.91%
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of Virtus Health is 2026 1.37 . PEG Ratio (Price/Earnings-to-Growth) of Virtus Health was 2025 126.02 . It decreases by -98.91% lower compared to the previous year.
Access this data via the Eulerpool API
Virtus Health Stock analysis
What does Virtus Health do? Virtus Health Ltd is a company in the field of assisted reproduction and fertility, based in Sydney, Australia. Founded in 2007, the company is a leader in the development and application of innovative technologies and methods to help couples worldwide to become pregnant.
The business model of Virtus Health includes the provision of IVF treatments (In-vitro Fertilization), IUI treatments (Intrauterine Insemination), egg donations, and other methods for successful fertilization of eggs and sperm cells. It is a highly specialized field that requires expertise and specialized skills.
The company owns and operates a number of specialized fertility clinics in Australia, Ireland, Denmark, Singapore, and the United Arab Emirates. These clinics offer patients all services related to assisted reproduction, including specialist consultation and advice, treatment planning, medical treatments, surgical interventions, medication administration, and aftercare.
As part of its business model, Virtus Health also operates a variety of laboratories where embryos are cultured and genetic and prenatal diagnostic procedures are performed. The company continuously invests in research and development, the development of new technologies, and the exploration of new markets in this field. Virtus Health is constantly seeking new ways to improve pregnancy rates for its patients.
The company is divided into different divisions, each offering different services for assisted reproduction. For example, Virtus Health operates the brand "IVFAustralia," the leading Australian clinic for assisted reproduction, where patients receive the best possible medical care for all questions regarding fertilization technologies.
Virtus Health is also diversified and offers various services in the field of assisted reproduction. For example, it operates the "California Cryobank," one of the world's largest sperm banks specializing in the storage and provision of sperm cells for assisted fertilization. Other product lines of the company include "OTIC Americas," a laboratory firm for medical devices, and "AAB College," an educational institute for medical personnel in Kosovo.
An important aspect of Virtus Health's business model is its close collaboration with other companies in the industry. This allows for better support for both patients and the market as a whole. Over the years, the company has formed partnerships with other medical institutions.
Overall, Virtus Health is a leading provider of services in the field of assisted reproduction and fertility. It is a specialized company that offers a variety of services to help couples expand their families. Virtus Health is a good example of a company that prioritizes the needs of its customers through innovation, efficiency, and high-quality services. Virtus Health is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Virtus Health stock
PEG Ratio (Price/Earnings-to-Growth) of Virtus Health is 1.37 in 2026.
Access this data via the Eulerpool API
Valuation — Virtus Health
All Key Metrics — Virtus Health
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth